A retrospective evaluation of routine isotretinoin laboratory monitoring in patients older than 35 years

J Am Acad Dermatol. 2021 Jan;84(1):201-202. doi: 10.1016/j.jaad.2020.04.106. Epub 2020 Apr 25.

Authors

Priyank Sharma¹, Elizabeth Tkachenko¹, Arash Mostaghimi²

Affiliations

¹ Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
² Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: amostaghimi@bwh.harvard.edu.

PMID: 32344069
DOI: 10.1016/j.jaad.2020.04.106

No abstract available

Publication types

Letter

MeSH terms

Acne Vulgaris / drug therapy*
Adolescent
Adult
Age Factors
Alanine Transaminase / blood
Cholesterol / blood
Dermatologic Agents / administration & dosage*
Dermatologic Agents / adverse effects
Humans
Isotretinoin / administration & dosage*
Isotretinoin / adverse effects
Leukocyte Count
Male
Middle Aged
Platelet Count
Retrospective Studies
Triglycerides / blood
Young Adult

Substances

Dermatologic Agents
Triglycerides
Cholesterol
Alanine Transaminase
Isotretinoin